Previous Statements by LNDC
» Landec's CEO Presents at Acquisition of GreenLine Foods, Inc. Conference (Transcript)
» Landec Corporation's CEO Discusses F3Q 2012 Results - Earnings Call Transcript
» Landec's CEO Discusses F2Q2012 Results - Earnings Call Transcript
» Landec Corporation CEO Discusses F1Q 2012 Results - Earnings Call Transcript
Yesterday in our earnings release we reported very good fourth quarter and fiscal year 2012 results. During fiscal year 2012, we achieved record levels of revenues and strong earnings and cash flow from operations along with substantial growth in overall unit volume sales.As reported, we finished the year strong with the fourth quarter revenues increasing 21% to $82.6 million and fourth quarter net income increasing $5.5 million to $2.8 million, compared to a loss of $2.7 million during the fourth quarter of last year. For all of fiscal year 2012, revenues increased 15% to a record $317.6 million and net income of $12.7 million or $0.49 a share. They grew 46% compared to fiscal year 2011 and after excluding the $4.8 million goodwill write-off in fiscal year 2011 of our Landec Ag, our former seed subsidiary. In addition, we increased cash flow from operations by 53% to $22.2 million. Our results reflect a shift in our strategy starting several years ago, a shift to focus on core businesses build on our material science technology in ways where we can control our own success. We are now focused on two core businesses, food and Biomedical materials. In the food business, we recognize substantial growth opportunities as consumers continue to seek healthy, convenient, fresh-cut produce food choices. In the Biomedical materials area, we recognize opportunities for using our polymer materials in high margin value-added Biomedical materials applications. To increase growth in revenues and margins in our food business, in April of this year we acquired GreenLine Foods, which is an ideal synergistic match with our Apio food business. In fiscal year 2013, the year that we started on June 1st, GreenLine is projected to contribute $95 million to $100 million in revenues and $10 million to $11 million in EBITDA. In 2011, we invested in Windset Farms. As we saw advantages in using hydroponic greenhouse techniques to grow high quality produced throughout the year with consistently high yields.
From our 20% ownership investment in Windset, we received 7.5% annual dividend and a 20% share of the increase in their fair market value, which when combined contributed approximately $7 million to pre-tax income in 2012 and that’s on a $15 million original investment.And to pursue opportunities in the Biomedical materials sector. In 2010, we acquired Lifecore Biomedical, which in 2012 contributed $34 million in revenues and over 30% EBITDA margins. With these investments we are now focused on integrating GreenLine assisting Windset Farms and doubling its California greenhouse growing capacity, and expanding Lifecore’s customer base and product offerings. We’ve taken steps to further focus and rationalize our business. We recently announced the sale of our Landec Ag seed coating business to INCOTEC, a leading provider of seed and coating technology products and services to the seed industry. While we plan to continue to support our licensing partner applications for materials. We are directing most of our R&D spending in support of our core food and Biomedical materials businesses. As reflected in our financial and business results, we had a very good fiscal year 2012 and we plan to continue our growth path for fiscal year 2013. For fiscal year 2013, we plan to grow Landec revenues by approximately 30% and net income by 25 to 35% compared to fiscal year 2012. Let me turn over to Greg for discussion of this specific results. Greg Skinner Thank you, Gary, and good morning, everyone. In yesterday’s news release, Landec reported that for the fourth quarter of fiscal year 2012, revenues increased 21% to $8.6 million versus revenues of $68.1 million for the fourth quarter of last year. The increase in total revenues during this year’s fourth quarter, compared to last year’s fourth quarter was primarily due to, first, $9.1 million of revenues from GreenLine; second, a $5.2 million increase in revenues Apio’s non-GreenLine value-added businesses, which include the Apio fresh-cut specialty packaged vegetable business, Apio Cooling and Apio Packaging; and third, a $1.3 million increase in revenues at Lifecore. Read the rest of this transcript for free on seekingalpha.com